carboplatin concentrate for solution for infusion 10mg/ml (600mg/60ml)
fresenius kabi oncology plc - carboplatin - concentrate for solution for infusion - carboplatin 10 mg/ml - antineoplastic agents
carboplatin 10mg/ml solution for infusion
central procurement & supplies unit ub002 industrial estate, san gwann sgn 3000, malta - carboplatin - solution for infusion - carboplatin 10 mg/ml - antineoplastic agents
carboplatin injection, solution
meitheal pharmaceuticals inc. - carboplatin (unii: bg3f62ond5) (carboplatin - unii:bg3f62ond5) - carboplatin 10 mg in 1 ml - carboplatin injection is indicated for the initial treatment of advanced ovarian carcinoma in established combination with other approved chemotherapeutic agents. one established combination regimen consists of carboplatin and cyclophosphamide. two randomized controlled studies conducted by the ncic and swog with carboplatin versus cisplatin, both in combination with cyclophosphamide, have demonstrated equivalent overall survival between the two groups (see clinical studies ). there is limited statistical power to demonstrate equivalence in overall pathologic complete response rates and long-term survival (≥3 years) because of the small number of patients with these outcomes: the small number of patients with residual tumor <2 cm after initial surgery also limits the statistical power to demonstrate equivalence in this subgroup. carboplatin injection is indicated for the palliative treatment of patients with ovarian carcinoma recurrent after prior chemotherapy, including patients who have been previously trea
hospira carboplatin 10 mg/ml injection, 50 mg/5 ml vial
hospira australia pty ltd - carboplatin, quantity: 10 mg/ml - injection - excipient ingredients: water for injections - carboplatin injection is indicated for the treatment of certain types of lung cancer and ovarian cancer.
carborex
rex medical ltd - carboplatin 10 mg/ml - solution for injection - 10 mg/ml - active: carboplatin 10 mg/ml excipient: water for injection - carboplatin is indicated in the treatment of: · advanced stage ovarian cancer of epithelial origin.
carboplatin 10mg/ml concentrate for solution for infusion 10mg/ml concentrate for solution for infusion
accord healthcare limited - carboplatin - concentrate for solution for infusion - 10mg/ml
carboplatin 10mg/ml concentrate for solution for infusion 10mg/ml concentrate for solution for infusion
accord healthcare limited - carboplatin - concentrate for solution for infusion - 10mg/ml
carboplatin 10mg/ml concentrate for solution for infusion 10mg/ml concentrate for solution for infusion
accord healthcare limited - carboplatin - concentrate for solution for infusion - 10mg/ml
carboplatin 10mg/ml concentrate for solution for infusion 10mg/ml concentrate for solution for infusion
accord healthcare limited - carboplatin - concentrate for solution for infusion - 10mg/ml
carboplatin 10mg/ml concentrate for solution for infusion 10mg/ml concentrate for solution for infusion
accord healthcare limited - carboplatin - concentrate for solution for infusion - 10mg/ml